1. Forging a modern generation of polyphenol‐based therapeutics
   Bernice Wright, 2013, British Journal of Pharmacology CrossRef
2. Resveratrol inhibits cell viability and proliferation via apoptotic pathways in ovarian cancer
   Jing-ping YAO et al, 2018, African Journal of Biotechnology CrossRef
3. Potential roles of berries in the prevention of breast cancer progression
   Patricia Reboredo-Rodríguez et al, 2018, Journal of Berry Research CrossRef
4. Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells
   M. H. Jeong et al, 2014, Journal of Radiation Research CrossRef
5. The effects of bioactive compounds from plant foods on mitochondrial function: A focus on apoptotic mechanisms
   Tamara Y. Forbes-Hernández et al, 2014, Food and Chemical Toxicology CrossRef
6. Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma
   In-Sung Song et al, 2018, Cancer Letters CrossRef
7. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells
   Dong Hwan Kim et al, 2017, Oncology Reports CrossRef
8. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells
   JIN-AH KIM et al, 2014, International Journal of Oncology CrossRef
9. Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight
   Mohammad Waseem et al, 2023, International Journal of Molecular Sciences CrossRef
10. Capilliposide Isolated fromLysimachia capillipesHemsl. Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Human Nonsmall Cell Lung Cancer Cell Lines
    Zheng-hua Fei et al, 2014, Evidence-Based Complementary and Alternative Medicine CrossRef
11. Resveratrol Enhances Apoptosis in Endometriotic Stromal Cells
    Ayumi Taguchi et al, 2016, American Journal of Reproductive Immunology CrossRef
12. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
    Dona Sinha et al, 2016, Seminars in Cancer Biology CrossRef
13. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model
    Dong Hwan Kim et al, 2017, International Journal of Oncology CrossRef
14. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
    Adele Chimento et al, 2019, International Journal of Molecular Sciences CrossRef
15. In Vitro Genotoxicity Assessment of a Novel Resveratrol Analogue, HS-1793
    Min Ho Jeong et al, 2014, Toxicological Research CrossRef
16. Demethoxycurcumin induces the apoptosis of human lung cancer NCI-H460 cells through the mitochondrial-dependent pathway
    YANG-CHING KO et al, 2015, Oncology Reports CrossRef
17. Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol
    Christine Meyer et al, 2024, Nutrients CrossRef
18. Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells
    Sanjay Kumar et al, 2017, Oncotarget CrossRef
19. Cancer Chemoprevention by Phytochemicals: Nature’s Healing Touch
    Haseeb Zubair et al, 2017, Molecules CrossRef
20. Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation
    Wol Soon Jo et al, 2022, Food Science and Biotechnology CrossRef
21. HS-1793 protects C2C12 cells from oxidative stress via mitochondrial function regulation
    Jubert Marquez et al, 2020, Molecular & Cellular Toxicology CrossRef
22. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells
    DONG HWAN KIM et al, 2013, International Journal of Oncology CrossRef